245 related articles for article (PubMed ID: 34324651)
1. Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome.
Nettersheim FS; Lemties J; Braumann S; Geißen S; Bokredenghel S; Nies R; Hof A; Winkels H; Freeman BA; Klinke A; Rudolph V; Baldus S; Mehrkens D; Mollenhauer M; Adam M
Cardiovasc Res; 2022 Jul; 118(9):2211-2225. PubMed ID: 34324651
[TBL] [Abstract][Full Text] [Related]
2. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
[TBL] [Abstract][Full Text] [Related]
4. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome.
Oller J; Méndez-Barbero N; Ruiz EJ; Villahoz S; Renard M; Canelas LI; Briones AM; Alberca R; Lozano-Vidal N; Hurlé MA; Milewicz D; Evangelista A; Salaices M; Nistal JF; Jiménez-Borreguero LJ; De Backer J; Campanero MR; Redondo JM
Nat Med; 2017 Feb; 23(2):200-212. PubMed ID: 28067899
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
7. Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1
Chen JZ; Sawada H; Ye D; Katsumata Y; Kukida M; Ohno-Urabe S; Moorleghen JJ; Franklin MK; Howatt DA; Sheppard MB; Mullick AE; Lu HS; Daugherty A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2538-2550. PubMed ID: 34407634
[TBL] [Abstract][Full Text] [Related]
8. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
[TBL] [Abstract][Full Text] [Related]
9. Lineage-Specific Induced Pluripotent Stem Cell-Derived Smooth Muscle Cell Modeling Predicts Integrin Alpha-V Antagonism Reduces Aortic Root Aneurysm Formation in Marfan Syndrome Mice.
Nakamura K; Dalal AR; Yokoyama N; Pedroza AJ; Kusadokoro S; Mitchel O; Gilles C; Masoudian B; Leipzig M; Casey KM; Hiesinger W; Uchida T; Fischbein MP
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1134-1153. PubMed ID: 37078287
[TBL] [Abstract][Full Text] [Related]
10. Accelerated Marfan syndrome model recapitulates established signaling pathways.
Gensicke NM; Cavanaugh NB; Andersen ND; Huang T; Qian L; Dyle MC; Turek JW
J Thorac Cardiovasc Surg; 2020 May; 159(5):1719-1726. PubMed ID: 31272746
[TBL] [Abstract][Full Text] [Related]
11. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W
J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm.
Pedroza AJ; Tashima Y; Shad R; Cheng P; Wirka R; Churovich S; Nakamura K; Yokoyama N; Cui JZ; Iosef C; Hiesinger W; Quertermous T; Fischbein MP
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2195-2211. PubMed ID: 32698686
[TBL] [Abstract][Full Text] [Related]
13. The role of β-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome.
Wisler JW; Harris EM; Raisch M; Mao L; Kim J; Rockman HA; Lefkowitz RJ
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1516-27. PubMed ID: 26371162
[TBL] [Abstract][Full Text] [Related]
14. High-Fat Diet Has a Protective Sex-Dependent Effect on Aortic Aneurysm Severity in a Marfan Syndrome Mouse Model.
Lau C; Muthu ML; Siddiqui IF; Li L; Reinhardt DP
Can J Cardiol; 2023 Nov; 39(11):1553-1567. PubMed ID: 37482239
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIPK2 Alleviates Thoracic Aortic Disease in Mice With Progressively Severe Marfan Syndrome.
Caescu CI; Hansen J; Crockett B; Xiao W; Arnaud P; Spronck B; Weinberg A; Hashimoto T; Murtada SI; Borkar R; Gallo JM; Jondeau G; Boileau C; Humphrey JD; He JC; Iyengar R; Ramirez F
Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2483-2493. PubMed ID: 34320838
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome.
Lim WW; Dong J; Ng B; Widjaja AA; Xie C; Su L; Kwek XY; Tee NGZ; Jian Pua C; Schafer S; Viswanathan S; Cook SA
Circ Res; 2022 Mar; 130(5):728-740. PubMed ID: 35135328
[TBL] [Abstract][Full Text] [Related]
17. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.
Busnadiego O; Gorbenko Del Blanco D; González-Santamaría J; Habashi JP; Calderon JF; Sandoval P; Bedja D; Guinea-Viniegra J; Lopez-Cabrera M; Rosell-Garcia T; Snabel JM; Hanemaaijer R; Forteza A; Dietz HC; Egea G; Rodriguez-Pascual F
J Mol Cell Cardiol; 2015 Aug; 85():48-57. PubMed ID: 25988230
[TBL] [Abstract][Full Text] [Related]
19. Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice.
Parker SJ; Stotland A; MacFarlane E; Wilson N; Orosco A; Venkatraman V; Madrid K; Gottlieb R; Dietz HC; Van Eyk JE
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1112-H1126. PubMed ID: 30004239
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
